Skyhawk Therapeutics
PrivateLast Round
Series B
Sep 14, 2021
Total Funding Raised
$181M
Momentum Score
25 /100
Company Overview
Skyhawk Therapeutics is a biotechnology company that develops small molecule drugs aimed at correcting ribonucleic acid expression through proprietary technology that targets specific binding sites during the splicing process to address diseases caused by exon skipping.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skyhawk Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Skyhawk Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 14, 2021 | ||||
| Series A | Jun 26, 2018 | ||||
| Seed | Jan 23, 2018 |
Skyhawk Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| Agent Capital | Series A |
| Good Growth Capital | Seed |
| Bramalea Partners | Series B |
| Acks | Seed |
| GreatPoint Ventures | Series A |
| Fidelity Management & Research Company | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Aaron Deves appointed to lead commercialization efforts for SKY-0515.
- Aug 18, 2025
Will develop RNA-targeting small molecules for neurological diseases.
Skyhawk Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Skyhawk Therapeutics's valuation, stock price, and market status.
